Athenex to provide corporate and financial update for the third quarter 2022 on november 3, 2022

Buffalo, n.y., oct. 24, 2022 (globe newswire) -- athenex (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the company will provide a corporate and financial update for the third quarter 2022 on thursday, november 3, 2022, before the market opens. athenex's management team will host a conference call and live audio webcast at 8:00 a.m. eastern time.
ATNX Ratings Summary
ATNX Quant Ranking